Items where Author is "Ciurea, A."
Number of items: 4. 2022Mischlinger, J. and Jaeger, V. K. and Ciurea, A. and Gabay, C. and Hasler, P. and Mueller, R. B. and Siegrist, C. A. and Villiger, P. and Walker, U. A. and Hatz, C. and Bühler, S.. (2022) Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controls. Vaccine, 40 (33). pp. 4897-4904. 2020Burkhard, J. and Ciurea, A. and Gabay, C. and Hasler, P. and Müller, R. and Niedrig, M. and Fehr, J. and Villiger, P. and Visser, L. G. and de Visser, A. W. and Walker, U. A. and Hatz, C. and Bühler, S.. (2020) Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals. Vaccine, 38 (19). pp. 3610-3617. Schmid, N. and Ciurea, A. and Gabay, C. and Hasler, P. and Fehr, J. and Müller, R. and Villiger, P. and Walker, U. and Hatz, C. and Bühler, S.. (2020) Travel patterns, risk behaviour and health problems of travellers with rheumatic diseases compared to controls: a multi-centre, observational study. Travel Med Infect Dis, 38. p. 101818. 2010Finckh, A. and Ciurea, A. and Brulhart, L. and Möller, B. and Walker, U. A. and Courvoisier, D. and Kyburz, D. and Dudler, J. and Gabay, C. and Arthritis, . (2010) Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? Annals of the rheumatic diseases, Vol. 69, H. 2. pp. 387-393. |
